BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGTY
2726
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $48.1M | ﹤0.01% |
2,189,783
-77,766
| -3% | -$1.64M |
|
|
ZY
2727
DELISTED
Zymergen Inc. Common Stock
ZY
| $48M | ﹤0.01% |
+1,200,559
| New | +$47.4M |
|
2728
AnaptysBio
ANAB
$1.63B
| $48M | ﹤0.01% |
1,851,904
-244,234
| -12% | -$5.85M |
|
|
CNTB
2729
Connect Biopharma Holdings
CNTB
$137M
| $48M | ﹤0.01% |
2,458,132
+7,742
| +0.3% | +$129K |
|
2730
Scotiabank
BNS
$108B
| $47.8M | ﹤0.01% |
735,204
+53,332
| +8% | +$3.45M |
|
|
BOWX
2731
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
| $47.8M | ﹤0.01% |
4,158,000
| – | – |
|
|
ORC
2732
Orchid Island Capital
ORC
$1.28B
| $47.8M | ﹤0.01% |
1,841,075
+140,470
| +8% | +$3.9M |
|
2733
iShares Core S&P US Value ETF
IUSV
$27.6B
| $47.7M | ﹤0.01% |
662,340
-17,907
| -3% | -$1.29M |
|
2734
First Financial Corp
THFF
$979M
| $47.4M | ﹤0.01% |
1,161,132
-161,238
| -12% | -$7.15M |
|
2735
Grid Dynamics Holdings
GDYN
$600M
| $47.2M | ﹤0.01% |
3,141,831
+111,850
| +4% | +$1.75M |
|
2736
Ardelyx
ARDX
$1.21B
| $47.1M | ﹤0.01% |
6,218,896
+236,120
| +4% | +$1.75M |
|
2737
Aspen Aerogels
ASPN
$415M
| $47.1M | ﹤0.01% |
1,574,572
-282,176
| -15% | -$5.76M |
|
|
WTRU
2738
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
| $47.1M | ﹤0.01% |
823,673
+25,384
| +3% | +$1.5M |
|
2739
Relmada Therapeutics
RLMD
$571M
| $47.1M | ﹤0.01% |
1,470,107
-18,068
| -1% | -$628K |
|
2740
First Mid Bancshares
FMBH
$1.39B
| $47M | ﹤0.01% |
1,159,534
+114,290
| +11% | +$4.94M |
|
|
TRUE
2741
DELISTED
TrueCar
TRUE
| $46.9M | ﹤0.01% |
8,306,660
-912,033
| -10% | -$4.59M |
|
2742
Precigen
PGEN
$2.46B
| $46.9M | ﹤0.01% |
7,195,940
-179,685
| -2% | -$1.26M |
|
|
ICPT
2743
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $46.8M | ﹤0.01% |
2,344,158
-122,285
| -5% | -$2.42M |
|
2744
Great Southern Bancorp
GSBC
$889M
| $46.7M | ﹤0.01% |
866,355
-81,058
| -9% | -$4.55M |
|
2745
Rush Street Interactive
RSI
$2.67B
| $46.6M | ﹤0.01% |
3,803,957
+2,806,436
| +281% | +$37.7M |
|
|
VLDR
2746
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $46.4M | ﹤0.01% |
4,357,441
+3,571,327
| +454% | +$42.2M |
|
|
ZYXI
2747
DELISTED
Zynex
ZYXI
| $46.3M | ﹤0.01% |
3,281,590
-116,507
| -3% | -$1.61M |
|
2748
Carriage Services
CSV
$657M
| $46.3M | ﹤0.01% |
1,253,016
-92,662
| -7% | -$3.46M |
|
|
WTRE
2749
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $46.3M | ﹤0.01% |
1,323,337
-36,026
| -3% | -$1.26M |
|
2750
BioAtla
BCAB
$5.53M
| $46.3M | ﹤0.01% |
21,836
+2,489
| +13% | +$5.62M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.